Cann American Corp. (CNNA)

USD 0.0

(0.0%)

Market Cap (In USD)

2.21 Million

Revenue (In USD)

-

Net Income (In USD)

3821.55

Avg. Volume

315.36 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.0E-4-0.0077
PE
-
EPS
-
Beta Value
0.324
ISIN
US13764N2071
CUSIP
13764N207
CIK
1368620
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Jason R. Tucker
Employee Count
-
Website
https://www.cannamericancorp.com
Ipo Date
2011-02-14
Details
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.